FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

30018111000001108: Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93684501000001114 Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93684601000001113 Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Dihydrocodeine tartrate false Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Dihydrocodeine tartrate true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) 500 tablet Has AMP True Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start